Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies

Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies

Bibliographic Details
Main Authors: Elisabetta Bianchi, Matteo Vecellio, Lars Rogge
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
chronic inflammatory diseases
spondyloarthritis
interleukin-23
interleukin-17
psoriasis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.770275/full
id doaj-f5a996dfb6eb4a848790dd6062f781c5
record_format Article
spelling doaj-f5a996dfb6eb4a848790dd6062f781c52021-09-23T05:08:26ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-09-011210.3389/fimmu.2021.770275770275Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted TherapiesElisabetta Bianchi0Elisabetta Bianchi1Matteo Vecellio2Matteo Vecellio3Lars Rogge4Lars Rogge5Immunoregulation Unit, Department of Immunology, Institut Pasteur, Paris, FranceUnité Mixte de Recherche, Institut Pasteur/AP-HP Hôpital Cochin, Paris, FranceNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United KingdomDivision of Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center, IRCCS, Milan, ItalyImmunoregulation Unit, Department of Immunology, Institut Pasteur, Paris, FranceUnité Mixte de Recherche, Institut Pasteur/AP-HP Hôpital Cochin, Paris, Francehttps://www.frontiersin.org/articles/10.3389/fimmu.2021.770275/fullchronic inflammatory diseasesspondyloarthritisinterleukin-23interleukin-17psoriasis
collection DOAJ
language English
format Article
sources DOAJ
author Elisabetta Bianchi
Elisabetta Bianchi
Matteo Vecellio
Matteo Vecellio
Lars Rogge
Lars Rogge
spellingShingle Elisabetta Bianchi
Elisabetta Bianchi
Matteo Vecellio
Matteo Vecellio
Lars Rogge
Lars Rogge
Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies
Frontiers in Immunology
chronic inflammatory diseases
spondyloarthritis
interleukin-23
interleukin-17
psoriasis
author_facet Elisabetta Bianchi
Elisabetta Bianchi
Matteo Vecellio
Matteo Vecellio
Lars Rogge
Lars Rogge
author_sort Elisabetta Bianchi
title Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies
title_short Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies
title_full Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies
title_fullStr Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies
title_full_unstemmed Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies
title_sort editorial: role of the il-23/il-17 pathway in chronic immune-mediated inflammatory diseases: mechanisms and targeted therapies
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-09-01
topic chronic inflammatory diseases
spondyloarthritis
interleukin-23
interleukin-17
psoriasis
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.770275/full
work_keys_str_mv AT elisabettabianchi editorialroleoftheil23il17pathwayinchronicimmunemediatedinflammatorydiseasesmechanismsandtargetedtherapies
AT elisabettabianchi editorialroleoftheil23il17pathwayinchronicimmunemediatedinflammatorydiseasesmechanismsandtargetedtherapies
AT matteovecellio editorialroleoftheil23il17pathwayinchronicimmunemediatedinflammatorydiseasesmechanismsandtargetedtherapies
AT matteovecellio editorialroleoftheil23il17pathwayinchronicimmunemediatedinflammatorydiseasesmechanismsandtargetedtherapies
AT larsrogge editorialroleoftheil23il17pathwayinchronicimmunemediatedinflammatorydiseasesmechanismsandtargetedtherapies
AT larsrogge editorialroleoftheil23il17pathwayinchronicimmunemediatedinflammatorydiseasesmechanismsandtargetedtherapies
_version_ 1717370660850761728

Similar Items